$NOTE
FiscalNote Holdings, Inc.

2022 Q1 Form 10-Q Financial Statement

#000110465922061396 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $5.347M $2.989M
YoY Change 78.89%
Gross Profit $20.72M $14.36M
YoY Change 44.32%
Gross Profit Margin
Selling, General & Admin $1.922M $250.4K
YoY Change 667.58%
% of Gross Profit 9.27% 1.74%
Research & Development $6.018M $5.255M
YoY Change 14.52%
% of Gross Profit 29.04% 36.59%
Depreciation & Amortization $4.717M $3.428M
YoY Change 37.6%
% of Gross Profit 22.76% 23.87%
Operating Expenses $1.922M $250.4K
YoY Change 667.58%
Operating Profit -$1.922M -$250.4K
YoY Change 667.59%
Interest Expense $9.135M $3.705M
YoY Change 146.56%
% of Operating Profit
Other Income/Expense, Net $22.53K $45.52K
YoY Change -50.51%
Pretax Income $7.236M $3.500M
YoY Change 106.73%
Income Tax -$374.0K -$3.189M
% Of Pretax Income -5.17% -91.11%
Net Earnings $7.236M $3.500M
YoY Change 106.73%
Net Earnings / Revenue
Basic Earnings Per Share -$1.06
Diluted Earnings Per Share $330.8K $160.0K
COMMON SHARES
Basic Shares Outstanding 18.76M
Diluted Shares Outstanding 18.76M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $213.3K $147.9K
YoY Change 44.25%
Cash & Equivalents $213.3K $147.9K
Short-Term Investments
Other Short-Term Assets $353.4K $691.7K
YoY Change -48.92%
Inventory
Prepaid Expenses $353.4K
Receivables $14.82M
Other Receivables $0.00
Total Short-Term Assets $566.7K $839.6K
YoY Change -32.51%
LONG-TERM ASSETS
Property, Plant & Equipment $31.62M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $175.1M $175.1M
YoY Change 0.03%
Other Assets $3.814M
YoY Change
Total Long-Term Assets $175.1M $175.1M
YoY Change 0.03%
TOTAL ASSETS
Total Short-Term Assets $566.7K $839.6K
Total Long-Term Assets $175.1M $175.1M
Total Assets $175.7M $175.9M
YoY Change -0.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.811M $99.97K
YoY Change 1711.53%
Accrued Expenses $3.973M $148.2K
YoY Change 2581.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $18.07M
YoY Change
Total Short-Term Liabilities $6.087M $248.2K
YoY Change 2352.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $16.68M $23.23M
YoY Change -28.19%
Total Long-Term Liabilities $16.68M $23.23M
YoY Change -28.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.087M $248.2K
Total Long-Term Liabilities $16.68M $23.23M
Total Liabilities $22.76M $23.47M
YoY Change -3.02%
SHAREHOLDERS EQUITY
Retained Earnings -$22.07M -$22.56M
YoY Change -2.15%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$22.07M -$22.56M
YoY Change
Total Liabilities & Shareholders Equity $175.7M $175.9M
YoY Change -0.13%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $7.236M $3.500M
YoY Change 106.73%
Depreciation, Depletion And Amortization $4.717M $3.428M
YoY Change 37.6%
Cash From Operating Activities -$404.9K -$88.21K
YoY Change 358.98%
INVESTING ACTIVITIES
Capital Expenditures -$2.128M -$1.211M
YoY Change 75.72%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$3.643M
YoY Change -100.0%
Cash From Investing Activities -$2.128M -$4.854M
YoY Change -56.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 236.1K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -404.9K -88.21K
Cash From Investing Activities -2.128M -4.854M
Cash From Financing Activities 0.000 236.1K
Net Change In Cash -404.9K 147.9K
YoY Change -373.81%
FREE CASH FLOW
Cash From Operating Activities -$404.9K -$88.21K
Capital Expenditures -$2.128M -$1.211M
Free Cash Flow $1.723M $1.123M
YoY Change 53.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001823466
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
213000
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
8/F Printing House
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
6 Duddell Street
CY2022Q1 dei Entity Shell Company
EntityShellCompany
true
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
213287
CY2022Q1 dei Entity Address Country
EntityAddressCountry
HK
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei City Area Code
CityAreaCode
852
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
3468 6200
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity File Number
EntityFileNumber
001-39672
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
DUDDELL STREET ACQUISITION CORP.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
618138
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
353372
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
462473
CY2022Q1 us-gaap Assets Current
AssetsCurrent
566659
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1080611
CY2022Q1 us-gaap Assets Held In Trust
AssetsHeldInTrust
175124335
CY2021Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
175101805
CY2022Q1 us-gaap Assets
Assets
175690994
CY2021Q4 us-gaap Assets
Assets
176182416
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1810983
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1736244
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3973397
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2942445
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
302160
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6086540
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4678689
CY2022Q1 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
6125000
CY2021Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
6125000
CY2022Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
10552500
CY2021Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
19687500
CY2022Q1 us-gaap Liabilities
Liabilities
22764040
CY2021Q4 us-gaap Liabilities
Liabilities
30491189
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22073483
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29309210
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-22073046
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-29308773
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
175690994
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176182416
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1921803
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
250369
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1921803
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-250369
CY2022Q1 us-gaap Interest Income Other
InterestIncomeOther
22530
CY2021Q1 us-gaap Interest Income Other
InterestIncomeOther
45521
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9135000
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3705000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
7235727
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3500152
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-29308773
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
7235727
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-22073046
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-26057518
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3500152
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-22557366
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
7235727
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3500152
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
22530
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
45520
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9135000
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3705000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-109101
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-98068
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
74739
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
95674
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1030952
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-31580
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
302160
CY2021Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
0
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-404851
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-88206
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
CY2021Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
411692
CY2022Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
0
CY2021Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
175626
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
236066
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-404851
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
147860
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
618138
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
213287
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
147860
CY2022Q1 dsac Working Capital Deficit
WorkingCapitalDeficit
5500000
CY2022Q1 dsac Working Capital Loans
WorkingCapitalLoans
0
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The preparation of the unaudited consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2022Q1 dsac Investments Maximum Maturity Term
InvestmentsMaximumMaturityTerm
P185D
CY2022Q1 dsac Class Of Warrant Or Right Adjustment Of Redemption Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price1
ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1
1
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q4 dsac Deferred Underwriting Fees Payable Non Current
DeferredUnderwritingFeesPayableNonCurrent
6100000
CY2020Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
17500000
CY2020Q3 dsac Sponsor Agreed Description
SponsorAgreedDescription
The Sponsor agreed to surrender for no consideration 656,250 founder shares when the option to purchase additional units was not exercised by the underwriters.
CY2022Q1 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
300000
CY2022Q1 dsac Working Capital Loan Amount
WorkingCapitalLoanAmount
1500000
CY2022Q1 dsac Price Per Share Warrants
PricePerShareWarrants
1.00
CY2022Q1 dsac Maximum Number Of Demands For Registration Of Securities
MaximumNumberOfDemandsForRegistrationOfSecurities
3
CY2022Q1 dsac Underwriting Discount Per Unit
UnderwritingDiscountPerUnit
0.20
CY2022Q1 dsac Deferred Underwriting Fees Amount Payable
DeferredUnderwritingFeesAmountPayable
3500000
CY2022Q1 dsac Additional Unit Per Shares
AdditionalUnitPerShares
0.35
CY2022Q1 dsac Aggregate Deferred Underwriting Commission
AggregateDeferredUnderwritingCommission
6100000
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 dsac Threshold Conversion Ratio Of Stock
ThresholdConversionRatioOfStock
1
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
15750000
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
15750000
CY2022Q1 dsac Warrants And Rights Outstanding Exercisable Term From Closing Of Business Combination
WarrantsAndRightsOutstandingExercisableTermFromClosingOfBusinessCombination
P30D
CY2022Q1 dsac Warrants And Rights Outstanding Exercisable Term From Closing Of Initial Public Offering
WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering
P12M
CY2022Q1 dsac Maximum Thres Hold Period For Filing Registration Statement After Business Combination
MaximumThresHoldPeriodForFilingRegistrationStatementAfterBusinessCombination
P15D
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2022Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2022Q1 dsac Threshold Issue Price For Capital Raising Purposes In Connection With Closing Of Business Combination
ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination
9.20
CY2022Q1 dsac Percentage Of Gross Proceeds On Total Equity Proceeds
PercentageOfGrossProceedsOnTotalEquityProceeds
0.60
CY2022Q1 dsac Threshold Trading Days For Calculating Market Value
ThresholdTradingDaysForCalculatingMarketValue
20
CY2022Q1 dsac Threshold Issue Price For Capital Raising Purposes In Connection With Closing Of Business Combination
ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination
9.20
CY2022Q1 dsac Class Of Warrant Or Right Adjustment Of Exercise Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price
ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice
1.15
CY2022Q1 dsac Class Of Warrant Or Right Adjustment Of Redemption Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price2
ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice2
1.80
CY2022Q1 dsac Common Stock Trading Days On Which Fair Market Value Of Shares Is Reported
CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported
10
CY2022Q1 dsac Multiplier Used In Calculating Warrant Exercise Price
MultiplierUsedInCalculatingWarrantExercisePrice
0.361
CY2022Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
175124335
CY2022Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
10552500
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
175101805
CY2021Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
19687500

Files In Submission

Name View Source Status
0001104659-22-061396-index-headers.html Edgar Link pending
0001104659-22-061396-index.html Edgar Link pending
0001104659-22-061396.txt Edgar Link pending
0001104659-22-061396-xbrl.zip Edgar Link pending
dsac-20220331.xsd Edgar Link pending
dsac-20220331x10q.htm Edgar Link pending
dsac-20220331x10q_htm.xml Edgar Link completed
dsac-20220331xex31d1.htm Edgar Link pending
dsac-20220331xex31d2.htm Edgar Link pending
dsac-20220331xex32d1.htm Edgar Link pending
dsac-20220331xex32d2.htm Edgar Link pending
dsac-20220331_cal.xml Edgar Link unprocessable
dsac-20220331_def.xml Edgar Link unprocessable
dsac-20220331_lab.xml Edgar Link unprocessable
dsac-20220331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending